Lifting non-pharmaceutical interventions following the COVID-19 pandemic – the quiet before the storm?

References

• World Health Organization [Internet]. WHO; c2022. Timeline: WHO’s COVID-19 response; 2020 [updated 28 Mar 2022; cited 13 Dec]; [ about 2 screens]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline?gclid=CjwKCAjwkdL6BRAREiwA-kiczOSDJ1iAFGB74uYaWtY33SRgkrzMfOaE5JrFZXlCOF58SVAW_QdT7xoCzlkQAvD_BwE#event-71
   Google Scholar
• Shen Y, Powell G, Ganser I, et al. Monitoring non-pharmaceutical public health interventions during the COVID-19 pandemic. Sci Data. 2021;8(1):225.
   PubMed Web of Science ®Google Scholar
• Hale T, Angrist N, Goldszmidt R, et al. A global panel database of pandemic policies (Oxford COVID-19 government response tracker). Nat Hum Behav. 2021;5(4):529–538.
   PubMed Web of Science ®Google Scholar
• Our World in Data [Internet]. OurWorldInData.org. Covid-19 Stringency Index; 2021 [cited 2021 Dec 10]; [ about 1screen]. Available from: https://ourworldindata.org/grapher/covid-stringency-index?tab=chart
   Google Scholar
• Askitas N, Tatsiramos K, Verheyden B. Estimating worldwide effects of non-pharmaceutical interventions on COVID-19 incidence and population mobility patterns using a multiple-event study. Sci Rep. 2021;11(1):1972.
   PubMed Web of Science ®Google Scholar
• Mendez-Brito A, El Bcheraoui C, Pozo-Martin F. Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19. J Infect. 2021;83(3):281–293.
   PubMed Web of Science ®Google Scholar
• Flaxman S, Mishra S, Gandy A, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584(7820):257–261.
   PubMed Web of Science ®Google Scholar
• Walker P, Whittaker C, Watson O, et al. Report 12: the global impact of COVID-19 and strategies for mitigation and suppression. Imperial College London; 2020. 2020 Mar 26.
   Google Scholar
• Müller O, Razum O, Jahn A, Effects of non-pharmaceutical interventions against COVID-19 on the incidence of other diseases. Lancet Reg Health Eur. 2021;6:100139.
   PubMedGoogle Scholar
• International Monetary Fund. Chapter 2: dissecting the economic effects. In: World economic outlook, October 2020: a long and difficult ascent. Washington (DC): International Monetary Fund; 2020. p. 65–84.
   Google Scholar
• Geng M-J, Zhang H-Y, L-J Y, et al., Changes in notifiable infectious disease incidence in China during the COVID-19 pandemic. Nat Commun. 2021;12(1):6923.
   PubMed Web of Science ®Google Scholar
• Maison N, Peck A, Illi S, et al., The rising of old foes: impact of lockdown periods on “non-SARS-CoV-2” viral respiratory and gastrointestinal infections. Infection. 2022;50(2):519–524.
   PubMed Web of Science ®Google Scholar
• Baker RE, Park SW, Yang W, et al. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020;117(48):30547–30553.
   PubMed Web of Science ®Google Scholar
• Cohen R, Pettoello-Mantovani M, Somekh E, et al. European pediatric societies call for an implementation of regular vaccination programs to contrast the immune debt associated to COVID-19 pandemic in children. J Pediatr. 2022;242:260–261.e3.
   PubMed Web of Science ®Google Scholar
• Adegbija O, Walker J, Smoll N, et al. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia. Commun Dis Intell (2018). 2021;45.
   Google Scholar
• Yeoh DK, Foley DA, Minney-Smith CA, et al. Impact of coronavirus disease 2019 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter. Clin Infect Dis. 2021;72(12):2199–2202.
   PubMed Web of Science ®Google Scholar
• Xiao J, Dai J, Hu J, et al. Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: a large population-based observational study. Lancet Reg Health West Pac. 2021;17:100282.
   PubMedGoogle Scholar
• Ullrich A, Schranz M, Rexroth U, et al. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: an analysis of national surveillance data during week 1-2016 - week 32-2020. Lancet Reg Health Eur. 2021;6:100103.
   PubMedGoogle Scholar
• Kim JH, Roh YH, Ahn JG, et al. Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19. Int J Infect Dis. 2021;110:29–35.
   PubMed Web of Science ®Google Scholar
• Grochowska M, Ambrożej D, Wachnik A, et al., The impact of the COVID-19 pandemic lockdown on pediatric infections-a single-center retrospective study. Microorganisms. 2022;10(1):178.
   PubMed Web of Science ®Google Scholar
• Chiu NC, Chi H, Tai YL, et al. Impact of wearing masks, hand hygiene, and social distancing on influenza, enterovirus, and all-cause pneumonia during the coronavirus pandemic: retrospective national epidemiological surveillance study. J Med Internet Res. 2020;22(8):e21257.
   PubMed Web of Science ®Google Scholar
• Hatoun J, Correa ET, Donahue SMA, et al. Social distancing for COVID-19 and diagnoses of other infectious diseases in children. Pediatrics. 2020;146(4):e2020006460.
   PubMed Web of Science ®Google Scholar
• Olsen SJ, Winn AK, Budd AP, et al. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic-United States, 2020-2021. Am J Transplant. 2021;21(10):3481–3486.
   PubMed Web of Science ®Google Scholar
• Chiapinotto S, Sarria EE, Mocelin HT, et al. Impact of non-pharmacological initiatives for COVID-19 on hospital admissions due to pediatric acute respiratory illnesses. Paediatr Respir Rev. 2021;39:3–8.
   PubMed Web of Science ®Google Scholar
• Friedrich F, Ongaratto R, Scotta MC, et al. Early impact of social distancing in response to coronavirus disease 2019 on hospitalizations for acute bronchiolitis in infants in Brazil. Clin Infect Dis. 2021;72(12):2071–2075.
   PubMed Web of Science ®Google Scholar
• Kishimoto K, Bun S, Shin JH, et al. Early impact of school closure and social distancing for COVID-19 on the number of inpatients with childhood non-COVID-19 acute infections in Japan. Eur J Pediatr. 2021;180(9):2871–2878.
   PubMed Web of Science ®Google Scholar
• UK Health Security Agency. Invasive meningococcal disease in England: annual laboratory confirmed reports for epidemiological year 2020 to 2021. UK Health Security Agency; 2022. ( Health Protection Report; Volume 16 Number 1).
   Google Scholar
• Danino D, Ben-Shimol S, van der Beek BA, et al. Decline in pneumococcal disease in young children during the coronavirus disease 2019 (COVID-19) pandemic in Israel associated with suppression of seasonal respiratory viruses, despite persistent pneumococcal carriage: a prospective cohort study. Clin Infect Dis. 2021;30. DOI:10.1093/cid/ciab1014.
   Web of Science ®Google Scholar
• Chan KF, Ma TF, Ip MS, et al. Invasive pneumococcal disease, pneumococcal pneumonia and all-cause pneumonia in Hong Kong during the COVID-19 pandemic compared with the preceding 5 years: a retrospective observational study. BMJ Open. 2021;11(10):e055575.
   PubMed Web of Science ®Google Scholar
• Chan CP, Wong NS, Leung CC, et al. Positive impact of measures against COVID-19 on reducing influenza in the Northern Hemisphere. J Travel Med. 2020;27(8):taaa087.
   PubMed Web of Science ®Google Scholar
• Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 pandemic - United States, Australia, Chile, and South Africa, 2020. MMWR. 2020;69(37):1305–1309.
   PubMed Web of Science ®Google Scholar
• Tempia S, Walaza S, Bhiman JN, et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021;26(29):2001600.
   Google Scholar
• Varela FH, Scotta MC, Polese-Bonatto M, et al. Absence of detection of RSV and influenza during the COVID-19 pandemic in a Brazilian cohort: likely role of lower transmission in the community. J Glob Health. 2021;11:05007.
   PubMed Web of Science ®Google Scholar
• Oh DY, Buda S, Biere B, et al. Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: analysis of national surveillance data. Lancet Reg Health Eur. 2021;6:100112.
   PubMedGoogle Scholar
• Torres-Fernandez D, Casellas A, Mellado MJ, et al. Acute bronchiolitis and respiratory syncytial virus seasonal transmission during the COVID-19 pandemic in Spain: a national perspective from the pediatric Spanish Society (AEP). J Clin Virol. 2021;145:105027.
   PubMed Web of Science ®Google Scholar
• Foley DA, Yeoh DK, Minney-Smith CA, et al. The interseasonal resurgence of respiratory syncytial virus in Australian children following the reduction of coronavirus disease 2019-related public health measures. Clin Infect Dis. 2021;73(9):e2829–e2830.
   PubMedGoogle Scholar
• Delestrain C, Danis K, Hau I, et al. Impact of COVID-19 social distancing on viral infection in France: a delayed outbreak of RSV. Pediatr Pulmonol. 2021;56(12):3669–3673.
   PubMed Web of Science ®Google Scholar
• Williams TC, Sinha I, Barr IG, et al. Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic. Euro Surveill. 2021;26(29):2100186.
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): Centers for Disease Control and Prevention. Increased interseasonal respiratory syncytial virus (RSV) activity in parts of the southern United States; 2021 [cited 14 Dec 2021]; [about 5 screens]. Available from: https://emergency.cdc.gov/han/2021/han00443.asp
   Google Scholar
• Giraud-Gatineau A, Kaba L, Boschi C, et al. Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures. J Clin Virol. 2022;150-151:105163.
   PubMed Web of Science ®Google Scholar
• Rodgers L, Sheppard M, Smith A, et al. Changes in seasonal respiratory illnesses in the United States during the coronavirus disease 2019 (COVID-19) pandemic. Clin Infect Dis. 2021;73(Suppl 1):S110–S117.
   PubMed Web of Science ®Google Scholar
• Netea MG, Giamarellos-Bourboulis EJ, Domínguez-Andrés J, et al. Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection. Cell. 2020;181(5):969–977.
   PubMed Web of Science ®Google Scholar
• Cohen R, Ashman M, Taha MK, et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021;51(5):418–423.
   PubMedGoogle Scholar
• Fourgeaud J, Toubiana J, Chappuy H, et al. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France. Eur J Clin Microbiol Infect Dis. 2021;40(11):2389–2395.
   PubMed Web of Science ®Google Scholar
• Together Against Flu [Internet]. IFPMA; c2022. What are the main issues concerning the next flu season?; 2021 [cited 15 Dec 2021]; [about 6 screens]. Available from: https://togetheragainstflu.com/news/interview-richard-webby
   Google Scholar
• Ujiie M, Tsuzuki S, Nakamoto T, et al. Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan. Emerg Infect Dis. 2021;27(11):2969–2970.
   PubMed Web of Science ®Google Scholar
• Yasmin F, Ali SH, Ullah I. Norovirus outbreak amid COVID-19 in the United Kingdom; priorities for achieving control. J Med Virol. 2021;94(3):1232–1235.
   PubMed Web of Science ®Google Scholar
• O’Reilly KM, Sandman F, Allen D, et al. Predicted norovirus resurgence in 2021-2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modelling study. BMC Med. 2021;19(1):299.
   PubMed Web of Science ®Google Scholar
• World Health Organization [Internet]. WHO; c2022. Severe acute hepatitis of unknown aetiology in children - Multi-country; 2022 [cited 2022 Jul 11]; [ about 18 screens]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON394
   Google Scholar
• World Health Organization. Guiding principles for immunization activities during the COVID-19 pandemic. WHO; 2020. (Interim guidance; 2020 Mar 26).
   Google Scholar
• Feldman AG, O’Leary ST, Danziger-Isakov L. The risk of resurgence in vaccine-preventable infections due to coronavirus disease 2019-related gaps in immunization. Clin Infect Dis. 2021;73(10):1920–1923.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Angelillo IF, Villani A, et al. Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: let’s avoid adding epidemics to the pandemic: appeal from the board of the vaccination calendar for life in Italy: maintain and increase coverage also by re-organizing vaccination services and reassuring the population. Vaccine. 2021;39(8):1187–1189.
   PubMed Web of Science ®Google Scholar
• Dembiński Ł, Huss G, Radziewicz-Winnicki I, et al. EAP and ECPCP statement risks for children’s health during the COVID-19 pandemic and a call for maintenance of essential pediatric services. Front Pediatr. 2021;9:679803.
   PubMed Web of Science ®Google Scholar
• Wong YJ, Lee SWH. COVID-19: a call for awareness or mandatory vaccination even in pandemics? J Glob Health. 2021;11:03005.
   PubMed Web of Science ®Google Scholar
• Santos VS, Vieira SCF, Barreto IDC, et al. Effects of the COVID-19 pandemic on routine pediatric vaccination in Brazil. Expert Rev Vaccines. 2021;20(12):1661–1666.
   PubMed Web of Science ®Google Scholar
• Taine M, Offredo L, Drouin J, et al. Mandatory infant vaccinations in France during the COVID-19 pandemic in 2020. Front Pediatr. 2021;9:666848.
   PubMed Web of Science ®Google Scholar
• Din M, Ali H, Khan M, et al. Impact of COVID-19 on polio vaccination in Pakistan: a concise overview. Rev Med Virol. 2021;31(4):e2190.
   PubMed Web of Science ®Google Scholar
• Saitoh A, Okabe N. Changes and remaining challenges for the Japanese immunization program: closing the vaccine gap. Vaccine. 2021;39(22):3018–3024.
   PubMed Web of Science ®Google Scholar
• Chandir S, Siddiqi DA, Mehmood M, et al. Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: an analysis of provincial electronic immunization registry data. Vaccine. 2020;38(45):7146–7155.
   PubMed Web of Science ®Google Scholar
• McDonald HI, Tessier E, White JM, et al. Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020. Eurosurveillance. 2020;25(19):2000848.
   Web of Science ®Google Scholar
• Silveira MF, Tonial CT, Goretti KMA, et al. Missed childhood immunizations during the COVID-19 pandemic in Brazil: analyses of routine statistics and of a national household survey. Vaccine. 2021;39(25):3404–3409.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Clapham HE, Aishworiya R, et al. Childhood vaccinations: hidden impact of COVID-19 on children in Singapore. Vaccine. 2021;39(5):780–785.
   PubMed Web of Science ®Google Scholar
• Cotter SB, Taylor LL, Grace R, et al. Effects of the COVID-19 pandemic on routine maternal vaccine uptake <Q176/>. Obstetrics Gynecol. 2022;139(139):51S.
   Google Scholar
• World Health Organization [Internet]. WHO; c2022. At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF; 2020 [cited 13 Dec 2021]; [about 9 screns]. Available from: https://www.who.int/news/item/22-05-2020-at-least-80-million-children-under-one-at-risk-of-diseases-such-as-diphtheria-measles-and-polio-as-covid-19-disrupts-routine-vaccination-efforts-warn-gavi-who-and-unicef
   Google Scholar
• World Health Organization. Pulse survey on continuity of essential health services during the COVID-19 pandemic. WHO; 2021. ( Quarter 1 2021).
   Google Scholar
• Skolnik A, Bhatti A, Larson A, et al. Silent consequences of COVID-19: why it’s critical to recover routine vaccination rates through equitable vaccine policies and practices. Ann Fam Med. 2021;19(6):527–531.
   PubMed Web of Science ®Google Scholar
• GAVI. 2022. Routine immunisation worldwide holds firm despite the pandemic; 2021 [cited 8 Apr 2022]; [ about 8 screens]. Available from: https://www.gavi.org/vaccineswork/routine-immunisation-worldwide-holds-firm-despite-pandemic
   Google Scholar
• Martinón-Torres F, Aramburo A, Martinón-Torres N, et al. A reverse evidence of rotavirus vaccines impact. Hum Vaccin Immunother. 2013;9(6):1289–1291.
   PubMed Web of Science ®Google Scholar
• van den Hof S, Meffre CM, Conyn-van Spaendonck MA, et al. Measles outbreak in a community with very low vaccine coverage, the Netherlands. Emerg Infect Dis. 2001;7(3 Suppl):593–597.
   PubMed Web of Science ®Google Scholar
• Abbas K, Procter SR, van Zandvoort K, et al. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Lancet Glob Health. 2020;8(10):e1264–e1272.
   PubMed Web of Science ®Google Scholar
• O’Sullivan N, O’Sullivan G, Van Harten M. The impact of the COVID-19 pandemic on the uptake of the seasonal influenza vaccine. Ir Med J. 2021;114(2):269.
   Google Scholar
• Bertoni L, Roncadori A, Gentili N, et al. How has COVID-19 pandemic changed flu vaccination attitudes among an Italian cancer center healthcare workers? Hum Vaccin Immunother. 2022;18(1):1978795.
   PubMed Web of Science ®Google Scholar
• Bachtiger P, Adamson A, Chow -J-J, et al. The impact of the COVID-19 pandemic on the uptake of influenza vaccine: UK-wide observational study. JMIR Public Health Surveill. 2021;7(4):e26734.
   PubMedGoogle Scholar
• Morris T, Tate J. Influenza vaccination during the COVID-19 pandemic. Planning and delivering vaccination programs to protect the most vulnerable people. London: The Health Policy Partnership; 2021.
   Google Scholar
• UK Health Security Agency. Pertussis vaccination programme for pregnant women update: vaccine coverage in England, October to December 2021. UK Health Security Agency; 2022. ( Health Protection Report; Volume 16 4).
   Google Scholar
• Anderson E, Brigden A, Davies A, et al. Maternal vaccines during the Covid-19 pandemic:A qualitative interview study with UK pregnant women. Midwifery. 2021;100:103062.
   PubMed Web of Science ®Google Scholar
• Bellizzi S, Panu Napodano CM, Pinto S, et al. COVID-19 and seasonal influenza: the potential 2021-22 “Twindemic” Vaccine. 2022;40(24):3286–3287.
   PubMed Web of Science ®Google Scholar
• Melidou A, Ködmön C, Nahapetyan K, et al. Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22. Euro Surveill. 2022;27(15):2200255.
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Atlanta (GA): Centers for Disease Control and Prevention. 2021-2022 U.S. Flu season: preliminary in-season burden estimates; 2022 updated 17 Jun 2022; cited 11 Jul 2022]; [about 5 screens. Available from: https://www.cdc.gov/flu/about/burden/preliminary-in-season-estimates.htm
   Google Scholar
• European Centre for Disease Prevention and Control [Internet]. Stockholm: ECDC; c2022. Influenza virus characterisation - Summary Europe, March 2022; [updated 21 Apr 2022; cited 11 Jul 2022]; [about 3 screens]. Available from: https://www.ecdc.europa.eu/en/publications-data/influenza-virus-characterisation-summary-europe-march-2022
   Google Scholar
• Martínez-Baz I, Casado I, Miqueleiz A, et al. Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22. Euro Surveill. 2022;27(26):2200488.
   Google Scholar
• World Health Organization [Internet]. WHO; c2022. UNICEF and WHO warn of perfect storm of conditions for measles outbreaks, affecting children; 2022 cited 02 May 2022]; [about 7 screens]. Available from: https://www.who.int/news/item/27-04-2022-unicef-and-who-warn-of–perfect-storm–of-conditions-for-measles-outbreaks–affecting-children
   Google Scholar
• UNICEF [Internet]. UNICEF. Measles cases are spiking globally; 2022 cited 10 Jul 2022]; [about 6 screens]. Available from: https://www.unicef.org/stories/measles-cases-spiking-globally
   Google Scholar
• The Global Polio Eradication Initiative [Internet]. Swizerland: WHO; 2016. Endemic countries; 2022 [cited 2022 Jul 10; [ about 3 screens]. Available from: https://polioeradication.org/where-we-work/polio-endemic-countries
   Google Scholar
• United Nations [Internet]. United Nations. First polio outbreak in 30 years declared in Mozambique; 2022 [cited 2022 Jul 11]; [ about 5 screens]. Available from: https://news.un.org/en/story/2022/05/1118502
   Google Scholar
• World Health Organization [Internet]. WHO; c2022. Disease Outbreak News; Wild poliovirus type 1 (WPV1) - Malawi; 2022 [cited 2022 Jul 11]; [ about 5 screens]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/wild-poliovirus-type-1-(WPV1)-malawi
   Google Scholar
• UK Health Security Agency [Internet]. UK Health Security Agency. Poliovirus detected in sewage from North and East London; 2022 cited 2022 Jul 11; [ about 5 screens]. Available from: https://www.gov.uk/government/news/poliovirus-detected-in-sewage-from-north-and-east-london
   Google Scholar
• Havers FP, Moro PL, Hariri S, et al. Pertussis. In: Hall E, Wodi AP, Hamborsky J, et al. editors. Epidemiology and prevention of vaccine-preventable diseases. 14th. Washington (DC): Public Health Foundation; 2021. p. 239–254.
   Google Scholar
• Brueggemann AB, Jansen van Rensburg MJ, Shaw D, et al. Changes in the incidence of invasive disease due to streptococcus pneumoniae, haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360–e370.
   PubMedGoogle Scholar
• Amin-Chowdhury Z, Bertran M, Sheppard CL, et al. Does the rise in seasonal respiratory viruses foreshadow the return of invasive pneumococcal disease this winter? Lancet Respir Med. 2022;10(1):e1–e2.
   PubMedGoogle Scholar
• Commission for Infectious Diseases and Vaccination Issues of the DAKJ (German Academy for Pediatric and Adolescent Medicine). Medizinische Maßnahmen bei immigrierenden Kindern und Jugendlichen – aktualisierung vom 07.10.2013. Stellungnahme der Kommission für Infektionskrankheiten und Impffragen [Medical measures for immigrant children and young people – updated 07.10.2013. Opinion of the Commission on Infectious Diseases and Vaccination]. Monatsschr Kinderheilkd. 2014;162:56–61. In German.
   Google Scholar
• Haute Autorité de Santé.Catch-up vaccination for newly arrived migrants in the event of unknown, incomplete or incompletely known immunisation status. Haute Autorité de Santé; 2019.
   Google Scholar
• Centers for Disease Control and Prevention [Internet]. Centers for Disease Control and Prevention. Catch-up immunization schedule for children and adolescents who start late or who are more than 1 month behind; updated 17 Feb 2022; cited 11 Jul 2022]; [about 38 screens]. Available from: https://www.cdc.gov/vaccines/schedules/hcp/imz/catchup.html
   Google Scholar
• Privor-Dumm LA, Poland GA, Barratt J, et al. A global agenda for older adult immunization in the COVID-19 era: a roadmap for action. Vaccine. 2021;39(37):5240–5250.
   PubMed Web of Science ®Google Scholar
• Nam LH, Chiu C-H, Heo JY, et al. The need for pertussis vaccination among older adults and high-risk groups: a perspective from advanced economies of the Asia pacific region. Expert Rev Vaccines. 2021;20(12):1603–1617.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global tuberculosis report 2021. Geneva: WHO; 2021.
   Google Scholar
• World Health Organization [Internet]. WHO; c2022. Ten threats to global health in 2019; 2019 cited 13 Dec 2021]; [about 18 screens. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
   Google Scholar
• Bayliss J, Randhawa R, Oh KB, et al. Perceptions of vaccine preventable diseases in Australian healthcare: focus on pertussis. Hum Vaccin Immunother. 2021;17(2):344–350.
   PubMed Web of Science ®Google Scholar
• Menzies RI, Leask J, Royle J, et al. Vaccine myopia: adult vaccination also needs attention. Med J Aust. 2017;206(6):238–239.
   PubMed Web of Science ®Google Scholar
• Wilson RJ, Paterson P, Jarrett C, et al. Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review. Vaccine. 2015;33(47):6420–6429.
   PubMed Web of Science ®Google Scholar
• Cavaliere AF, Zaami S, Pallottini M, et al. Flu and tdap maternal immunization hesitancy in times of COVID-19: an Italian survey on multiethnic sample. Vaccines (Basel). 2021;9(10):1107.
   PubMed Web of Science ®Google Scholar
• Laupèze B, Del Giudice G, Doherty MT, et al. Vaccination as a preventative measure contributing to immune fitness. NPJ Vaccines. 2021;6(1):93.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Communicable disease threats report. Week 7, 13-19 February 2022. ECDC; 2022.
   Google Scholar
• Government of Western Australia [Internet]. Government of Western Australia. Pertussis notifications. Notifiable infectious diseases reports, WA Department of Health; 2022 cited 2022 Apr 12; [ about 4 screens]. Available from: https://ww2.health.wa.gov.au/Articles/N_R/Notifiable-infectious-disease-report?report=pertussis
   Google Scholar
• Communicable Disease Control Branch [Internet]. Government of South Australia. Rotavirus chart; 2022 [cited 2022 Apr 12; [ about 1 screen]. Available from: https://www.sahealth.sa.gov.au/wps/wcm/connect/281a3d8042fb3067bb9abb9d0fd82883/Item+9_Rotavirus.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-281a3d8042fb3067bb9abb9d0fd82883-o0sqhvG
   Google Scholar
• UK Health Security Agency [Internet]. UK Helath Security Agency. Pneumococcal disease: cases caused by strains covered by Prevenar 13 vaccine; 2022 cited 2022 Apr 11; [ about 4 screens]. Available from: https://www.gov.uk/government/publications/pneumococcal-disease-cases-caused-by-strains-covered-by-prevenar-13-vaccine/pneumococcal-disease-cases-caused-by-strains-covered-by-prevenar-13-vaccine
   Google Scholar
• UK Health Security Agency. National norovirus and rotavirus bulletin: routine norovirus and rotavirus surveillance in England 2021 to 2022 season. 2021. (Week 40 report: data to week 38; 2021 Sept 26.
   Google Scholar
• Government of Western Australia [Internet]. Rotavirus notifications. Notifiable infectious diseases reports, WA Department of Health; 2022 [cited 2022 Apr 18]; [ about 3 screens]. Available from: https://ww2.health.wa.gov.au/Articles/N_R/Notifiable-infectious-disease-report?report=rotavirus
   Google Scholar
• Clark S, Campbell H, Mensah AA, et al. [Internet]. Elsevier. An increase in group B invasive meningococcal disease among adolescents and young adults in England following easing of COVID-19 containment measures; 2021 [cited 2022 Apr 11; [about 3 screens]. Available from: http://dx.doi.org/10.2139/ssrn.3998164
   Google Scholar
• Zheng Z, Pitzer VE, Shapiro ED, et al. Estimation of the timing and intensity of reemergence of respiratory syncytial virus following the COVID-19 pandemic in the US. JAMA Network Open. 2021;4(12):e2141779.
   PubMed Web of Science ®Google Scholar
• Reis J, Shaman J. Simulation of four respiratory viruses and inference of epidemiological parameters. Infect Dis Model. 2018;3:23–34.
   PubMedGoogle Scholar
• Gaythorpe KAM, Trotter CL, Lopman B, et al. Norovirus transmission dynamics: a modelling review. Epidemiol Infect. 2018;146(2):147–158.
   PubMed Web of Science ®Google Scholar
• Ma E, Fung C, Yip SH, et al. Estimation of the basic reproduction number of enterovirus 71 and coxsackievirus A16 in hand, foot, and mouth disease outbreaks. Pediatr Infect Dis J. 2011;30(8):675–679.
   PubMed Web of Science ®Google Scholar
• Chowell G, Miller MA, Viboud C. Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiol Infect. 2008;136(6):852–864.
   PubMed Web of Science ®Google Scholar
• Rid A, Lipsitch M, Miller FG. The ethics of continuing placebo in SARS-CoV-2 vaccine trials. JAMA. 2021;325(3):219–220.
   PubMed Web of Science ®Google Scholar
• Moll N. The research-based industry response to COVID-19; collaboration and innovation. Eur Pharm Rev. 2021;26(4):34–36.
   Google Scholar
• Machado BAS, Hodel KVS, Fonseca L, et al. The importance of RNA-based vaccines in the fight against COVID-19: an overview. Vaccines (Basel). 2021;9(11):1345.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Immunization Agenda 2030. WHO; 2020.
   Google Scholar